Halozyme Therapeutics, Inc. (HALO) on GreekSoup https://greeksoup.ai/stocks/us/halo/ Every dated entry in the public record on Halozyme Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 730 shares at $107.17 on 1 October 2026, $78,233https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-10-02:a8bd90dc9aFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 3,300 shares at $108.45 on 1 October 2026, $357,898https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-10-02:b95c0ebc95Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 1,100 shares at $109.57 on 1 October 2026, $120,526https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-10-02:a5d6fc7f8eFri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 100 shares at $110.04 on 1 October 2026, $11,004https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-10-02:c664932191Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-09-30:0498ceac38Wed, 30 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 8-K: material agreement, new financial obligation, unregistered sale of equityhttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-09-22:fb6ba9a6d5Tue, 22 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-09-18:2575191db7Fri, 18 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 3,100 shares at $106.13 on 16 September 2026, $329,009https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-17:5e8e0a2202Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 3,000 shares at $106.83 on 16 September 2026, $320,484https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-17:e5648b4f62Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 8,896 shares at $108.04 on 16 September 2026, $961,124https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-17:9bf2be4789Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Posard Matthew L. (Director) sold 4,000 shares at $108.99 on 16 September 2026, $435,964https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-17:0f45da5446Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-09-16:ca472c8df7Wed, 16 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Form 144, MATTHEW POSARD plans to sell 34,226 shares worth $3.6 million around 16 September 2026https://greeksoup.ai/stocks/us/halo/planned-sales/us:HALO:planned-sale:2026-09-16:61dfa664a4Wed, 16 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: short interest 15,154,414 shares at the 15 September 2026 settlement, 11.59 days to coverhttps://greeksoup.ai/stocks/us/halo/short-interest/us:HALO:short-interest:2026-09-15:4d57c8fefdTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 15,492 shares at $107.15 on 11 September 2026, $1.7 millionhttps://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:836a7934aeFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 4,508 shares at $107.55 on 11 September 2026, $484,826https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:b34c6e4320Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 14,588 shares at $107.01 on 10 September 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:2fd7dd1a0fFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 5,412 shares at $107.58 on 10 September 2026, $582,228https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:a6034d02d4Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 13,304 shares at $107.22 on 9 September 2026, $1.4 millionhttps://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:d5bbcb4affFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 6,596 shares at $107.82 on 9 September 2026, $711,187https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:43f5d4b236Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 100 shares at $108.67 on 9 September 2026, $10,867https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-09-11:5d5ef3a829Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: short interest 14,880,707 shares at the 31 August 2026 settlement, 8.69 days to coverhttps://greeksoup.ai/stocks/us/halo/short-interest/us:HALO:short-interest:2026-08-31:febbe77e16Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 7,200 shares at $106.36 on 19 August 2026, $765,778https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:96a28a018eWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 9,600 shares at $107.22 on 19 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:048d36456bWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 3,200 shares at $107.77 on 19 August 2026, $344,848https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:b45c6936c5Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 5,703 shares at $103.08 on 18 August 2026, $587,882https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:8e34e9fc63Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 4,897 shares at $104.11 on 18 August 2026, $509,827https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:cb1078944bWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 9,400 shares at $104.87 on 18 August 2026, $985,816https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:e10fb72ed2Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 900 shares at $98.96 on 17 August 2026, $89,062https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:2031e092bcWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 500 shares at $100.46 on 17 August 2026, $50,228https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:8f6e8af0d5Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 2,100 shares at $101.77 on 17 August 2026, $213,709https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:5f3935e181Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 9,000 shares at $102.55 on 17 August 2026, $922,977https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:e2521cf53aWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Torley Helen (PRESIDENT AND CEO) sold 7,500 shares at $103.48 on 17 August 2026, $776,115https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-19:e05840cb76Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-08-18:a1cf08c6e2Tue, 18 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Form 144, Helen Torley plans to sell 240,000 shares worth $23.7 million around 17 August 2026https://greeksoup.ai/stocks/us/halo/planned-sales/us:HALO:planned-sale:2026-08-17:366411c365Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: short interest 14,636,927 shares at the 14 August 2026 settlement, 5.01 days to coverhttps://greeksoup.ai/stocks/us/halo/short-interest/us:HALO:short-interest:2026-08-14:8ff9509cc6Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Form 144, CORTNEY A CAUDILL plans to sell 41,702 shares worth $4.3 million around 11 August 2026https://greeksoup.ai/stocks/us/halo/planned-sales/us:HALO:planned-sale:2026-08-11:d0a680ec69Tue, 11 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Connaughton Bernadette (Director) sold 1,626 shares at $102.80 on 10 August 2026, $167,153https://greeksoup.ai/stocks/us/halo/insiders/us:HALO:insider:2026-08-11:70bd4ec1acTue, 11 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: Form 144, BERNADETTE CONNAUGHTON plans to sell 1,626 shares worth $167,673 around 10 August 2026https://greeksoup.ai/stocks/us/halo/planned-sales/us:HALO:planned-sale:2026-08-10:92336d06b7Mon, 10 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. Q2 FY2026 results: revenue $481 million, net income $230 millionhttps://greeksoup.ai/stocks/us/halo/results/fy2026-q2/us:HALO:result:2026-08-06:87d86b7910Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-08-06:3126cb2c7dThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/halo/filings/us:HALO:filing:2026-08-06:a7a6f8d13cThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: short interest 14,022,134 shares at the 31 July 2026 settlement, 8.35 days to coverhttps://greeksoup.ai/stocks/us/halo/short-interest/us:HALO:short-interest:2026-07-31:0e468712a9Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Halozyme Therapeutics, Inc.: short interest 13,295,961 shares at the 15 July 2026 settlement, 7.27 days to coverhttps://greeksoup.ai/stocks/us/halo/short-interest/us:HALO:short-interest:2026-07-15:75bc4ce051Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>